Medical Logistics Inc. (NASDAQ: MDGL) filed its second-quarter 2026 financial results on July 30, 2026, covering the period ended June 30, 2026. The disclosure includes balance sheet data, equity composition, and details on the company's financing arrangements. The filing provides investors with an updated view of the company's financial position as of the end of the second quarter.

Key Points

  • NASDAQ: MDGL
  • Company filed quarterly financial disclosures for the period ended June 30, 2026
  • Filing was submitted on July 27, 2026, with the financial period ending on June 30, 2026
  • The disclosure includes equity structure, debt arrangements, and customer concentration metrics

Equity Structure and Capital Composition

The filing reveals the company's capital structure as of June 30, 2026, detailing preferred stock, common stock, additional paid-in capital, accumulated other comprehensive income, and retained earnings. The disclosure tracks these equity components across multiple reporting periods, including quarterly snapshots from 2024 through the second quarter of 2026. The report also references convertible Series A and B preferred stock as of the reporting date, indicating the presence of convertible securities in the company's capitalization.

Debt Facilities and Financing Arrangements

Medical Logistics disclosed details regarding its secured debt arrangements, including a loan facility dated May 31, 2022, with variable rate components. The filing also references financing agreements effective July 17, 2025, which include secured debt and delayed draw term loan facilities. These arrangements represent the company's external capital sourcing mechanisms and suggest active management of liquidity through structured lending relationships. The debt disclosures cover both historical facilities and recent financing updates.

Customer Concentration and Revenue Insights

The filing documents customer concentration risk across five identified customer groups designated as Customer A through Customer E. The company tracked revenue from contracts with these customers across multiple quarterly and semi-annual periods in 2025 and 2026. This metric indicates that Medical Logistics relies on a defined customer base and discloses the concentration of its revenue streams. The customer data spans from the first quarter of 2025 through the second quarter of 2026, providing a comparative view of customer relationships over time.

Cash and Investment Holdings

Medical Logistics maintained cash and cash equivalents, money market funds, and corporate debt securities as of June 30, 2026. The filing specifies U.S. Treasury and government securities with maturity profiles within one to two years, as well as corporate debt securities similarly categorized by maturity. The company's investment strategy reflects a diversified short-term liquidity position. The disclosure compares these holdings to prior-year figures as of December 31, 2025, allowing investors to assess changes in the company's liquid asset position.